AbbVie: Jeffrey R. Stewart plans $11.9M share sale

The securities are listed as acquired from AbbVie through a stock option exercise, with cash as the payment method.

Available on EDGAR 11/09/2026 - 04:07 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Jeffrey R. Stewart, an officer of AbbVie Inc., listed 40,619 common shares to be sold, with an approximate sale date of November 9, 2026. The listed aggregate market value is $11,925,848.07. The securities information lists 1,767,616,306 shares outstanding.

Key Figures

Shares listed for sale: 40,619 shares Aggregate market value: $11,925,848.07 Shares outstanding: 1,767,616,306 shares

3 metrics

Shares listed for sale 40,619 shares AbbVie common shares

Aggregate market value $11,925,848.07 Shares listed for sale

Shares outstanding 1,767,616,306 shares Securities information

Key Terms

Aggregate Market Value, Stock Option Exercise, Approximate Date of Sale

3 terms

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Stock Option Exercise financial

"Nature of Acquisition Transaction: Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Approximate Date of Sale financial

"Approximate Date of Sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ABBV shares did Jeffrey R. Stewart list for sale?

Jeffrey R. Stewart listed 40,619 AbbVie common shares to be sold, with an approximate sale date of November 9, 2026. The listed aggregate market value is $11,925,848.07.

How did Jeffrey R. Stewart acquire the ABBV shares listed for sale?

The 40,619 shares were acquired from AbbVie through a stock option exercise dated November 9, 2026; the payment method is listed as cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001761675
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABBVIE INC.
SEC File Number	001-35565
Address of Issuer	1 North Waukegan Road North Chicago ILLINOIS 60064-6400
Phone	847-932-7900
Name of Person for Whose Account the Securities are To Be Sold	JEFFREY R STEWART
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40619	11925848.07	1767616306	11/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/09/2026	Stock Option Exercise	Issuer			40619	11/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Jeffrey Ryan Stewart
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)